Evofem Biosciences (NASDAQ: EVFM) reported Q1 EPS of ($0.56), $0.07 worse than the analyst estimate of ($0.49). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $1.63 million.

For earnings history and earnings-related data on Evofem Biosciences (EVFM) click here.